121 related articles for article (PubMed ID: 7498293)
21. Manipulation of operant responding for an ethanol-paired conditioned stimulus in the rat by pharmacological alteration of the serotonergic system.
Wilson AW; Costall B; Neill JC
J Psychopharmacol; 2000; 14(4):340-6. PubMed ID: 11198050
[TBL] [Abstract][Full Text] [Related]
22. Potentiation of 5-HT1A receptor-mediated neuroendocrine responses in male but not female rat progeny after prenatal cocaine: evidence for gender differences.
Battaglia G; Cabrera TM
J Pharmacol Exp Ther; 1994 Dec; 271(3):1453-61. PubMed ID: 7996458
[TBL] [Abstract][Full Text] [Related]
23. Enhancement of serotonin-1A receptor dependent responses following withdrawal of haloperidol in rats.
Haleem DJ; Khan NH
Prog Neuropsychopharmacol Biol Psychiatry; 2003 Jun; 27(4):645-51. PubMed ID: 12787852
[TBL] [Abstract][Full Text] [Related]
24. Repeated cocaine modifies the neuroendocrine responses to the 5-HT1C/5-HT2 receptor agonist DOI.
Levy AD; Li Q; Alvarez Sanz MC; Rittenhouse PA; Brownfield MS; Van de Kar LD
Eur J Pharmacol; 1992 Oct; 221(1):121-7. PubMed ID: 1333968
[TBL] [Abstract][Full Text] [Related]
25. Pharmacological characterization of in vivo properties of putative mixed 5-HT1A agonist/5-HT(2A/2C) antagonist anxiolytics. II. Drug discrimination and behavioral observation studies in rats.
Kleven MS; Assié MB; Koek W
J Pharmacol Exp Ther; 1997 Aug; 282(2):747-59. PubMed ID: 9262338
[TBL] [Abstract][Full Text] [Related]
26. (1-(2,5-dimethoxy-4 iodophenyl)-2-aminopropane)-induced head-twitches in the rat are mediated by 5-hydroxytryptamine (5-HT) 2A receptors: modulation by novel 5-HT2A/2C antagonists, D1 antagonists and 5-HT1A agonists.
Schreiber R; Brocco M; Audinot V; Gobert A; Veiga S; Millan MJ
J Pharmacol Exp Ther; 1995 Apr; 273(1):101-12. PubMed ID: 7714755
[TBL] [Abstract][Full Text] [Related]
27. In vivo correlates of central serotonin function after high-dose fenfluramine administration.
Baumann MH; Ayestas MA; Rothman RB
Ann N Y Acad Sci; 1998 May; 844():138-52. PubMed ID: 9668672
[TBL] [Abstract][Full Text] [Related]
28. Hypothalamic-pituitary-adrenal responses to 5-HT1A and 5-HT2A/C agonists are differentially altered in female and male rats prenatally exposed to ethanol.
Hofmann CE; Ellis L; Yu WK; Weinberg J
Alcohol Clin Exp Res; 2007 Feb; 31(2):345-55. PubMed ID: 17250628
[TBL] [Abstract][Full Text] [Related]
29. Behavioural and neuroendocrine responses to D-fenfluramine in rats treated with neurotoxic amphetamines.
Series HG; le Masurier M; Gartside SE; Franklin M; Sharp T
J Psychopharmacol; 1995 Jan; 9(3):214-22. PubMed ID: 22297760
[TBL] [Abstract][Full Text] [Related]
30. Prenatal cocaine produces deficits in serotonin mediated neuroendocrine responses in adult rat progeny: evidence for long-term functional alterations in brain serotonin pathways.
Cabrera TM; Yracheta JM; Li Q; Levy AD; Van de Kar LD; Battaglia G
Synapse; 1993 Oct; 15(2):158-68. PubMed ID: 8259525
[TBL] [Abstract][Full Text] [Related]
31. Effects of fenfluramine on free-operant timing behaviour: evidence for involvement of 5-HT2A receptors.
Body S; Kheramin S; Ho MY; Miranda Herrera F; Bradshaw CM; Szabadi E
Psychopharmacology (Berl); 2004 Nov; 176(2):154-65. PubMed ID: 15103450
[TBL] [Abstract][Full Text] [Related]
32. Effects of repeated treatment with 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) on the autoregulatory control of dorsal raphe 5-HT neuronal firing and cortical 5-HT release.
Kidd EJ; Garratt JC; Marsden CA
Eur J Pharmacol; 1991 Jul; 200(1):131-9. PubMed ID: 1837523
[TBL] [Abstract][Full Text] [Related]
33. Genomic responses to 5-HT1A or 5-HT2A/2C receptor activation is differentially regulated in four regions of rat brain.
Tilakaratne N; Friedman E
Eur J Pharmacol; 1996 Jun; 307(2):211-7. PubMed ID: 8832223
[TBL] [Abstract][Full Text] [Related]
34. Schizophrenia-like disruptions of sensory gating by serotonin receptor stimulation in rats: effect of MDMA, DOI and 8-OH-DPAT.
Thwaites SJ; Gogos A; Van den Buuse M
Pharmacol Biochem Behav; 2013 Nov; 112():71-7. PubMed ID: 24120765
[TBL] [Abstract][Full Text] [Related]
35. Reduction of 5-hydroxytryptamine (5-HT)(1A)-mediated temperature and neuroendocrine responses and 5-HT(1A) binding sites in 5-HT transporter knockout mice.
Li Q; Wichems C; Heils A; Van De Kar LD; Lesch KP; Murphy DL
J Pharmacol Exp Ther; 1999 Dec; 291(3):999-1007. PubMed ID: 10565817
[TBL] [Abstract][Full Text] [Related]
36. Effects of 8-OH-DPAT, a 5-HT1A receptor agonist, and DOI, a 5-HT2A/2C agonist, on monosynaptic transmission in spinalized rats.
Hasegawa Y; Ono H
Brain Res; 1996 Oct; 738(1):158-61. PubMed ID: 8949941
[TBL] [Abstract][Full Text] [Related]
37. Tolerance to 3,4-methylenedioxymethamphetamine is associated with impaired serotonin release.
Jones K; Brennan KA; Colussi-Mas J; Schenk S
Addict Biol; 2010 Jul; 15(3):289-98. PubMed ID: 20477756
[TBL] [Abstract][Full Text] [Related]
38. Effects of intracerebroventricular administration of 5-HT receptor agonists on the maternal aggression of rats.
De Almeida RM; Lucion AB
Eur J Pharmacol; 1994 Nov; 264(3):445-8. PubMed ID: 7698186
[TBL] [Abstract][Full Text] [Related]
39. Repeated adolescent MDMA ("Ecstasy") exposure in rats increases behavioral and neuroendocrine responses to a 5-HT2A/2C agonist.
Biezonski DK; Courtemanche AB; Hong SB; Piper BJ; Meyer JS
Brain Res; 2009 Feb; 1252():87-93. PubMed ID: 19059385
[TBL] [Abstract][Full Text] [Related]
40. 5-hydroxytryptamine (5-HT)1A receptors and the tail-flick response. I. 8-hydroxy-2-(di-n-propylamino) tetralin HBr-induced spontaneous tail-flicks in the rat as an in vivo model of 5-HT1A receptor-mediated activity.
Millan MJ; Bervoets K; Colpaert FC
J Pharmacol Exp Ther; 1991 Mar; 256(3):973-82. PubMed ID: 1826033
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
